CD8A and neoplasm: The final effect of STING pathway activation is to awake CD8+ T cell-mediated anti-tumor immune responses: directly, by inducing the production of two T cell-recruiting cytokines, CCL5 and CXCL10, and, indirectly, through NK cell activation [14].